Peijia Medical IPO: Valuation Insights
Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijiahas launched a Hong Kong IPO to raise net...
384 Views
Peijia Medical (沛嘉医疗) IPO: Hot Deal at Discount
Peijia Medical launched book building to raise up to USD 302 million to list in Hong Kong. It is a leading domestic player in the transcatheter...
444 Views
ECM Weekly (3 May 2020) - JD.com, Hangzhou Tigermed, Peijia Medical, Central China New Life
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The...
308 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Deserves Valuation Premium for the TAVR Late Comer
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
420 Views
Peijia Medical IPO Initiation: Let's Have a Heart-To-Heart
Peijia Medical (1740651D CH) is a leading transcatheter heart valve medical device company in China. It has filed for a Hong Kong IPO and is...
344 Views